...
oncy-img

Oncolytics Biotech Inc, Common Stock

ONCY

NAQ

$0.768

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$59.74M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
300.97K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.75 L
$1.53 H
$0.768

About Oncolytics Biotech Inc, Common Stock

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameONCYSectorS&P500
1-Week Return-10.24%-3.39%0.2%
1-Month Return-22.51%-1.92%2.72%
3-Month Return-19.58%-10.54%7.31%
6-Month Return-23.66%-4.47%10.44%
1-Year Return-39.29%4.06%27.53%
3-Year Return-48.26%0.94%30.88%
5-Year Return-57.17%36.67%89.21%
10-Year Return-84.39%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue485.57K446.19K452.06K392.00K403.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.89,"profit":true},{"date":"2021-12-31","value":93.1,"profit":true},{"date":"2022-12-31","value":80.73,"profit":true},{"date":"2023-12-31","value":82.99,"profit":true}]
Gross Profit(485.57K)(446.19K)(452.06K)(392.00K)(403.00K)[{"date":"2019-12-31","value":-48557400,"profit":false},{"date":"2020-12-31","value":-44618700,"profit":false},{"date":"2021-12-31","value":-45206500,"profit":false},{"date":"2022-12-31","value":-39200000,"profit":false},{"date":"2023-12-31","value":-40300000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses20.69M25.46M26.23M26.92M33.79M[{"date":"2019-12-31","value":61.24,"profit":true},{"date":"2020-12-31","value":75.34,"profit":true},{"date":"2021-12-31","value":77.64,"profit":true},{"date":"2022-12-31","value":79.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(20.69M)(25.46M)(26.23M)(28.57M)(33.79M)[{"date":"2019-12-31","value":-2069335700,"profit":false},{"date":"2020-12-31","value":-2545900600,"profit":false},{"date":"2021-12-31","value":-2623494500,"profit":false},{"date":"2022-12-31","value":-2856900000,"profit":false},{"date":"2023-12-31","value":-3379100000,"profit":false}]
Total Non-Operating Income/Expense(12.25M)3.08M78.56K2.70M7.29M[{"date":"2019-12-31","value":-168.11,"profit":false},{"date":"2020-12-31","value":42.2,"profit":true},{"date":"2021-12-31","value":1.08,"profit":true},{"date":"2022-12-31","value":37.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(33.12M)(22.51M)(26.25M)(24.75M)(27.66M)[{"date":"2019-12-31","value":-3312288800,"profit":false},{"date":"2020-12-31","value":-2250505700,"profit":false},{"date":"2021-12-31","value":-2625485200,"profit":false},{"date":"2022-12-31","value":-2475100000,"profit":false},{"date":"2023-12-31","value":-2765500000,"profit":false}]
Income Taxes12.43M(2.95M)49.43K84.00K97.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-23.77,"profit":false},{"date":"2021-12-31","value":0.4,"profit":true},{"date":"2022-12-31","value":0.68,"profit":true},{"date":"2023-12-31","value":0.78,"profit":true}]
Income After Taxes(45.55M)(19.55M)(26.30M)(24.84M)(27.75M)[{"date":"2019-12-31","value":-4555241900,"profit":false},{"date":"2020-12-31","value":-1955110800,"profit":false},{"date":"2021-12-31","value":-2630427900,"profit":false},{"date":"2022-12-31","value":-2483500000,"profit":false},{"date":"2023-12-31","value":-2775200000,"profit":false}]
Income From Continuous Operations(33.12M)(22.51M)(26.30M)(24.84M)(32.36M)[{"date":"2019-12-31","value":-3312288800,"profit":false},{"date":"2020-12-31","value":-2250505700,"profit":false},{"date":"2021-12-31","value":-2630427900,"profit":false},{"date":"2022-12-31","value":-2483500000,"profit":false},{"date":"2023-12-31","value":-3235700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(45.55M)(19.55M)(26.30M)(24.84M)(27.75M)[{"date":"2019-12-31","value":-4555241900,"profit":false},{"date":"2020-12-31","value":-1955110800,"profit":false},{"date":"2021-12-31","value":-2630427900,"profit":false},{"date":"2022-12-31","value":-2483500000,"profit":false},{"date":"2023-12-31","value":-2775200000,"profit":false}]
EPS (Diluted)(0.93)(0.43)(0.49)(0.44)(0.41)[{"date":"2019-12-31","value":-93,"profit":false},{"date":"2020-12-31","value":-43,"profit":false},{"date":"2021-12-31","value":-49,"profit":false},{"date":"2022-12-31","value":-44,"profit":false},{"date":"2023-12-31","value":-41,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ONCY
Cash Ratio 2.56
Current Ratio 2.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ONCY
ROA (LTM) -71.33%
ROE (LTM) -138.22%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ONCY
Debt Ratio Lower is generally better. Negative is bad. 0.63
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.37

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ONCY
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 9.34
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Oncolytics Biotech Inc share price today?

Oncolytics Biotech Inc (ONCY) share price today is $0.768

Can Indians buy Oncolytics Biotech Inc shares?

Yes, Indians can buy shares of Oncolytics Biotech Inc (ONCY) on Vested. To buy Oncolytics Biotech Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ONCY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Oncolytics Biotech Inc be purchased?

Yes, you can purchase fractional shares of Oncolytics Biotech Inc (ONCY) via the Vested app. You can start investing in Oncolytics Biotech Inc (ONCY) with a minimum investment of $1.

How to invest in Oncolytics Biotech Inc shares from India?

You can invest in shares of Oncolytics Biotech Inc (ONCY) via Vested in three simple steps:

  • Click on Sign Up or Invest in ONCY stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Oncolytics Biotech Inc shares
What is Oncolytics Biotech Inc 52-week high and low stock price?

The 52-week high price of Oncolytics Biotech Inc (ONCY) is $1.53. The 52-week low price of Oncolytics Biotech Inc (ONCY) is $0.75.

What is Oncolytics Biotech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Oncolytics Biotech Inc (ONCY) is

What is Oncolytics Biotech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Oncolytics Biotech Inc (ONCY) is 9.34

What is Oncolytics Biotech Inc dividend yield?

The dividend yield of Oncolytics Biotech Inc (ONCY) is 0.00%

What is the Market Cap of Oncolytics Biotech Inc?

The market capitalization of Oncolytics Biotech Inc (ONCY) is $59.74M

What is Oncolytics Biotech Inc’s stock symbol?

The stock symbol (or ticker) of Oncolytics Biotech Inc is ONCY

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top